anti-programmed cell death ligand-1(PD-L1) therapyNSCLCICI-related pneumonitisNorthwestern UniversityIRP
… and accounting for 35% of ICI-related deaths in patients under anti-programmed cell death ligand-1(PD-L1) therapy. 1 Real-world studies have demonstrated higher incidence rates …